What diabetes regimen is appropriate for a 44-year-old homeless Hmong male with obesity, newly diagnosed diabetes (elevated hemoglobin A1c), leukocytosis, normal renal function, currently hospitalized for right lower extremity cellulitis with maggots?

Inpatient Diabetes Regimen for Newly Diagnosed Diabetes with Severe Infection

This patient requires immediate initiation of basal-bolus insulin therapy during hospitalization, with a starting total daily dose of 0.3-0.5 U/kg (approximately 40-65 units/day given his weight of 131.2 kg), divided as 50% basal insulin and 50% rapid-acting insulin before meals. 1, 2

Rationale for Insulin Therapy

With an A1c of 7.7% and active severe infection (cellulitis with maggots, WBC 23), this patient has significant stress hyperglycemia that demands insulin therapy. The acute infection creates insulin resistance and metabolic stress that oral agents cannot adequately address in the hospital setting 1.

Key Clinical Considerations:

• Severe soft tissue infection in diabetes significantly increases metabolic stress and insulin requirements 3
• Leukocytosis (WBC 23) indicates substantial inflammatory burden requiring aggressive glycemic control
• Newly diagnosed diabetes means no established outpatient regimen to reference
• Normal renal function (GFR >90) allows full-dose insulin without adjustment

Specific Inpatient Insulin Protocol

Initial Dosing Strategy:

Given his obesity (131.2 kg) and moderate hyperglycemia (A1c 7.7%), start conservatively:

• Total daily dose: 0.3-0.4 U/kg = 40-52 units/day (use lower end given newly diagnosed status) 1
• Basal insulin (glargine or detemir): 20-26 units once daily
• Rapid-acting insulin (lispro, aspart, or glulisine): 7-9 units before each meal (if eating)
• Correction insulin: Add supplemental rapid-acting per sliding scale for glucose >180 mg/dL

Important Modifications:

If poor oral intake or NPO status: Use basal-plus regimen instead—basal insulin at 0.1-0.25 U/kg/day (13-33 units) with correction doses every 6 hours 1, 2. This reduces hypoglycemia risk while maintaining glycemic control.

Critical Pitfalls to Avoid

⚠️ DO NOT use sliding scale insulin alone—this approach is explicitly discouraged by guidelines and leads to poor glycemic control 1, 2. Sliding scale should only supplement a basal-bolus regimen.

⚠️ DO NOT use premixed insulin (70/30)—unacceptably high hypoglycemia rates in hospital settings 1.

⚠️ DO NOT continue oral agents during acute severe infection—insulin is the only appropriate therapy for hospitalized patients with significant infection and metabolic stress 1, 2.

Glycemic Targets During Hospitalization

• Target range: 140-180 mg/dL for non-critically ill patients 2
• Monitor point-of-care glucose before meals and at bedtime
• Adjust insulin doses daily based on patterns, not just individual readings

Discharge Planning Considerations

Critical for this homeless patient:

Given homelessness, discharge planning must address:

1. Simplified regimen: Consider once-daily basal insulin (glargine U-300 or degludec for longer action) if adherence to multiple daily injections is questionable
2. Access to supplies: Connect with social work for insulin assistance programs, free clinic resources, and shelter-based medical services
3. Survival skills education: Focus on hypoglycemia recognition, basic glucose monitoring if possible, and when to seek emergency care 4
4. Transition timing: Begin subcutaneous insulin 24-48 hours before discharge to ensure stability 4

Realistic Outpatient Options:

For a homeless patient, once-daily basal insulin (0.2-0.3 U/kg) may be more practical than basal-bolus despite being less optimal, as adherence to complex regimens is extremely challenging without stable housing 5. However, given his A1c of 7.7% (not severely elevated), this simplified approach may achieve adequate control.

Alternative consideration: If patient demonstrates ability to manage multiple injections and has access to refrigeration through shelter services, continue basal-bolus regimen as this provides superior glycemic control 1.

Why Not Oral Agents Now?

While research shows that patients with A1c 7.7% could potentially achieve control with intensive oral therapy (metformin plus second agent) 6, the acute severe infection with maggot infestation makes insulin mandatory during hospitalization 1, 3. The metabolic stress, infection-related insulin resistance, and need for rapid glycemic control preclude oral agents in this acute setting.

Oral agents can be considered at discharge if social circumstances allow reliable medication access and the patient demonstrates understanding, but insulin remains the safer initial choice given the severity of presentation and uncertain follow-up 7.